|
Whole-body 18F-FDG PET combined with chest CT is cost-effective in pretreatment screening for distant metastases in head and neck squamous cell carcinoma patients with risk factors, according to a study published in the February issue of the Journal of Nuclear Medicine.
Research published in the December issue of the Journal of Nuclear Medicine suggests that 18F-FDG PET is a suitable routine post-treatment surveillance tool in oral and oropharyngeal squamous cell carcinoma patients, between three and six months after treatment and could detect malignancy not detected by regular follow up.
FDG-PET, when combined with CT, is far more effective in its capability to stage colorectal liver metastases than CT alone, according to a randomized controlled trial published in this month's Journal of Nuclear Medicine.
|
Research published in this month’s issue of Cancer suggests that early FDG-PET imaging during preoperative chemotherapy could identify patients with estrogen receptor-positive breast cancer tumors who will not respond optimally to preoperative chemotherapy.
Research presented at the 2009 European Association of Nuclear Medicine (EANM) conference in Barcelona, Spain, suggests that FDG PET is useful in monitoring response to antimycobacterial treatment in patients with pulmonary tuberculosis and can direct alternative therapy in case of resistant disease.
|
RSS 
The use of health IT to reduce rehospitalizations will be welcome but also disruptive, said Stephen Jencks, an independent consultant in healthcare safety during a Feb. 24 webinar on the potential use of health IT to mitigate rehospitalizations, sponsored by the Agency for Healthcare Research and Quality (AHRQ).
During the Health IT Standards Committee meeting on Feb. 24 in Washington, D.C., the Clinical Operations Workgroup sought to gather comments on proposed recommendations on implementation specifications for content exchange, vocabulary and code set standards for the Interim Final Rule of meaningful use.
In 2006, the Center for Devices and Radiological Health (CDRH), a branch of the FDA, began examining the number of medical device reports they received. Over the past two years, the number of submitted reports has increased, sparking a demand for the CDRH to make a move to electronic reporting.
A new hospital breaking ground usually isn’t breaking news. But the vision of patient care at one new facility, tentatively named Palomar Medical Center West (PMC West), is currently illegal under California state law.